FNB in ACL Recon Under GA
Launched by CHUNCHEON SACRED HEART HOSPITAL · Sep 19, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called a femoral nerve block, which is a way to manage pain during surgery for a condition known as an anterior cruciate ligament (ACL) rupture. The researchers want to see how well this technique works when combined with general anesthesia during arthroscopic surgery, a minimally invasive surgery that allows doctors to repair the ACL. The goal is to find out if this approach can improve pain management and recovery for patients.
To participate in this trial, individuals need to be scheduled for ACL reconstruction surgery and must provide informed consent, meaning they understand the study and agree to take part. However, not everyone will be eligible. For example, those who need additional surgeries for other knee injuries or who have had previous knee surgeries will not be included. The trial is not yet recruiting participants, but once it starts, those who join will receive detailed information about what to expect during the study and how their pain will be managed after surgery. This research is important as it could lead to better pain relief options for future patients undergoing similar procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • individuals who are scheduled to undergo arthroscopic anterior cruciate ligament reconstruction surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.
- Exclusion Criteria:
- • who require simultaneous surgery for concomitant cartilage injury, medial meniscus tear, and lateral collateral ligament tear.
- • who have previously undergone surgical treatment within the knee joint.
- • who have declined to participate in the research.
- • where medical, surgical, or anesthetic complications occurred during surgery.
- • other cases deemed necessary by the researchers.
About Chuncheon Sacred Heart Hospital
Chuncheon Sacred Heart Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Chuncheon, South Korea, the hospital is committed to delivering high-quality care while fostering a collaborative environment for researchers and healthcare professionals. With a focus on various therapeutic areas, Chuncheon Sacred Heart Hospital leverages its state-of-the-art facilities and experienced clinical teams to conduct rigorous trials that adhere to the highest ethical standards. The institution aims to enhance medical knowledge and contribute to the development of new treatments that address unmet patient needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chuncheon, Gangwon Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported